MODULAR ENDOGRAFT DEVICES AND ASSOCIATED SYSTEMS AND METHODS
Modular endograft devices and associated systems and methods are disclosed herein. In several embodiments, an endograft system can include a first endograft device and a second endograft device that each include an integrated frame, a cover and a lumen within the cover. Each endograft device further includes a superior portion and an inferior portion. The superior portion can have a convexly curved outer wall and a septal wall. The first and second endograft devices can be configured to extend into a low-profile configuration with a first cross-sectional dimension and a first length and self-expand into an expanded configuration with a second cross-sectional dimension greater than the first cross-sectional dimension and a second length less than the first length. In the expanded configuration, the septal walls can press against each other and form a septum between the lumens of the first and second endograft devices.
Latest Altura Medical, Inc. Patents:
The present application claims priority to each of the following. U.S. Provisional Applications:
(A) U.S. Provisional Application No. 61/265,713, filed on Dec. 1, 2009, entitled “IMPROVED SYSTEMS AND METHODS FOR MODULAR ABDOMINAL AORTIC ANEURYSM GRAFT;” and
(B) U.S. Provisional Application No. 61/293,581, filed Jan. 11, 2010, entitled “IMPROVED SYSTEMS AND METHODS FOR MODULAR ABDOMINAL AORTIC ANEURYSM GRAFT.”
All of the foregoing applications are incorporated herein by reference in their entireties.
TECHNICAL FIELDThe present technology generally relates to endograft devices and methods for percutaneous endovascular delivery of the endograft devices across aneurysms. In particular, several embodiments are directed toward a modular bi-luminal endograft device with independently positioned components for endovascular aneurysm repair.
BACKGROUNDAn aneurysm is a dilation of a blood vessel at least 1.5 times above its normal diameter. The dilated vessel can form a bulge known as an aneurysmal sac that can weaken vessel walls and eventually rupture. Aneurysms are most common in the arteries at the base of the brain (i.e., the Circle of Willis) and in the largest artery in the human body, the aorta. The abdominal aorta, spanning from the diaphragm to the aortoiliac bifurcation, is the most common site for aortic aneurysms. The frequency of abdominal aortic aneurysms (“AAAs”) results at least in part from decreased levels of elastins in the arterial walls of the abdominal aorta and increased pressure due to limited transverse blood flow.
Aneurysms are often repaired using open surgical procedures. Surgical methods for repairing AAAs, for example, require opening the abdominal region from the breast bone to the pelvic bone, clamping the aorta to control bleeding, dissecting the aorta to remove the aneurysmal section, and attaching a prosthetic graft to replace the diseased artery. The risks related to general anesthesia, bleeding, and infection in these types of open surgical repairs result in a high possibility of operative mortality. Thus, surgical repair is not a viable option for many patients. Moreover, the recovery process is extensive for the patients fit for surgical repair. An open surgical repair of an AAA generally requires seven days of post-operational hospitalization and, for uncomplicated operations, at least six to eight weeks of recovery time. Thus, it is a highly invasive and expensive procedure.
Minimally invasive surgical techniques that implant prosthetic grafts across aneurysmal regions of the aorta have been developed as an alternative or improvement to open surgery. Endovascular aortic repairs (“EVAR”), for example, generally require accessing an artery (e.g., the femoral artery) percutaneously or through surgical cut down, introducing guidewires into the artery, loading an endograft device into a catheter, and inserting the loaded catheter in the artery. With the aid of imaging systems (e.g., X-rays), the endograft device can be guided through the arteries and deployed from a distal opening of the catheter at a position superior to the aneurysm. From there, the endograft device can be deployed across the aneurysm such that blood flows through the endograft device and bypasses the aneurysm.
EVAR devices should be implanted at a precise location across the aneurysmal region and securely fixed to the vessel wall because improper placement, migration, and/or projection of the endograft device into branching vessels may interfere with the blood flow to nearby physiological structures. For example, to avoid impairing renal functions, the endograft device should not inhibit blood flow to the renal arteries. In addition to the variations in the vasculature between patients, the characteristics of the aneurysms themselves can also pose challenges because of the anatomical variations and the different structural features of individual aneurysms. For example, the vascular bifurcation at the iliac arteries and the angulation of aneurysmal sacs are both known to pose challenges to methods and devices for treating AAAs. Conventional systems address these challenges by having many different EVAR devices with different sizes and shapes.
Specific details of several embodiments of the technology are described below with reference to
With regard the use of “superior” and “inferior” within this application, inferior generally refers being situated below or directed downward, and superior generally refers to being situated above or directed upward.
With regard to the use of “expansion” and “constriction” within this application, expansion refers to a radial increase in a cross-sectional dimension of a device or component, and constriction refers to a radial decrease in the cross-sectional dimension of the device or component. For example,
With regard to the use of “contraction” and “extension” within this application, contraction refers to a longitudinal decrease in the length of a device or component, and extension refers to a longitudinal increase in the length of the device or component. For example,
With regard to the terms “distal” and “proximal” within this application, the terms can reference a relative position of the portions of an implantable device and/or a delivery device with reference to an operator. Proximal refers to a position closer to the operator of the device, and distal refers to a position that is more distant from the operator of the device.
1. Endograft System Structures
1.1 Selected Endograft Devices
As shown in
The superior portions 108 of the endograft devices 102 are mated together and at least substantially sealed along the septal walls 114 within the aorta above the aneurysm. In some embodiments, the superior portion 108 can be approximately 2-4 cm in length to adequately fix the outer walls 112 to the arterial walls such that they are at least substantially sealed together. In other embodiments, the superior portion 108 can be longer or shorter. In one embodiment in accordance with the technology, the inferior portions 110 can extend through an inferior portion of the aneurysm and into corresponding iliac arteries to bypass the aneurysm. In another embodiment, one or both inferior portions 110 can terminate within the aneurysm to form what is known to those skilled in the art as a “gate.” As described in further detail below, limbs (not shown) can be attached to the proximal ends of the inferior portions 110 and extended into the iliac arteries to bypass the aneurysm.
In the embodiment shown in
The end portions 118 can also increase the available structure for securing the endograft device 102 to the artery and increase the surface area of the covers 106 for sealably fixing the endograft devices 102 to arterial walls. This decreases the precision necessary to position the endograft devices 102 and increases the reliability of the implanted system 100. For example, a short infrarenal aortic neck (e.g., less than 2 cm) generally requires precise placement of the endograft devices 102 to preserve blood flow to the renal arteries while still providing enough surface area for the endograft devices 102 to be properly affixed with the aorta. In the embodiment shown in
During deployment of the system 100, each endograft device 102 can be delivered independently to an aneurysmal region in a low-profile configuration. The low-profile configuration has a first cross-sectional dimension and a first length that can facilitate percutaneous endovascular delivery of the system 100. Because each device 102 extends around only a portion of the vessel periphery, the individual endograft devices 102 can be constricted (i.e., radially collapsed) to a smaller diameter than conventional AAA devices with a single superior portion that extends around the complete periphery of the vessel wall. In some embodiments, for example, each of the endograft devices 102 can have a diameter of 25 mm in the expanded configuration, and can be constricted to a diameter of 4 mm in the low-profile configuration to be percutaneously deployed across the aneurysm through a 12 F catheter. Additionally, as described in more detail below, because each endograft device 102 is delivered independently, the end portions 118 and fenestrations can facilitate staggering the endograft devices 102 to accommodate asymmetrical anatomies.
At a target site in the aneurysmal region, the endograft devices 102 can self-expand to an expanded configuration (e.g., shown in
In operation, the system 100 can prevent blood from collecting in a diseased aneurysmal portion of a blood vessel (e.g., the aorta, the iliac arteries, etc.). Rather, the system 100 can direct blood into the lumens 116, funnel the blood through the superior and inferior portions 108 and 110, and discharge the blood into healthy portions of the iliac arteries, thereby at least substantially bypassing the aneurysm. The bifurcated system 100 facilitates independent positioning of the first and second endograft devices 102 to accommodate disparate structures and morphologies of the abdominal aorta and/or iliac arteries. For example, the first endograft device 102a can be positioned independently in a desired location without being constrained by a desired placement of the second endograft device 102b. Accordingly, the system 100 can easily adapt to a variety of different anatomies and thereby provide a modular alternative to customized endograft systems.
1.2 Select Embodiments of Superior Portions
In other embodiments, both the outer wall 212 and the septal wall 214 can be convexly curved such that the superior portion 208 forms a complex ellipsoid with at least two distinct radii.
Similarly, the superior portion 208 shown in
As shown in
1.3 Select Embodiments of Transition Portions
More specifically,
2. Endograft System Components
2.1 Integrated Frames
As shown
As shown in
In the expanded configuration shown in
Lower braid angles θ, however, can also adversely affect the extension and constriction of the frame 104 in the low-profile configuration shown in
In some embodiments in accordance with the technology, the braid angle θ can vary along the length of the frame 104 to vary kink resistance, outward spring force, hoop strength, and extension properties at different portions of the frame 104. For example, the braid angle θ can be higher at the superior portion 108 (e.g., 40°) such that the superior portion 108 can extend and constrict into the low-profile configuration, and the braid angle θ can be lower at the inferior portion 110 (e.g., 30°) to provide kink resistance where the frame 104 is most likely to bend (e.g., within the aneurysmal sac and toward the iliac arteries). The smaller braid angle θ at the inferior portion 110 may not adversely affect the profile of the frame 104 because the inferior portion 110 need not constrict as much as the superior portion 108 to reach the desired low-profile configuration. In other embodiments, the braid angle θ of the frame 104 may vary in another way.
The wires 426 can have a diameter sufficient to support the frame 104 while still providing substantial flexibility for the frame 104. The diameter of the wires 426 can be selected to attain a desired cross-sectional dimension in the low-profile configuration, a desired outward spring force to self-expand to the expanded configuration, and a desired hoop strength to support the frame 104 in the expanded configuration. For example, in some embodiments, the wires 426 can have a diameter from approximately 0.007 inch to approximately 0.014 inch. In specific embodiments, the wires have a diameter from approximately 0.011 inch to 0.013 inch. In other embodiments, the wires 426 can have a smaller diameter, a greater diameter, and/or the diameter of the wires 426 can vary along the length of the frame 104. For example, in one embodiment, the wires 426 can have a greater diameter at the superior portion 108 than at the inferior portion 110 such that the wires 426 of the superior portion 108 have a outward spring force and greater hoop strength where the first and second endograft devices mate (e.g., at the septal walls 114) and the increased density of wires 426 at the inferior portion 110 does not negatively impact the flexibility of the frame 104.
The frame 104 may be constructed from a variety of resilient metallic materials, polymeric materials (e.g., polyethylenes, polypropylenes, Nylons, PTFEs, and the like), and composites of materials. For example, the wires 426 can be made from biocompatible stainless steels, highly elastic metallic alloys, and biocompatible shape setting materials that exhibit shape memory properties. In some embodiments, for example, the wire 426 can be made from a shape setting alloy, such as Nitinol, that has a preferred or native configuration. For example, a Nitinol structure can be deformed or constrained into a secondary configuration, but upon release from the constraint, the structure returns toward its native configuration with high fidelity. Accordingly, a frame 104 made from Nitinol wires 426 can reliably self-expand from the low-profile configuration the expanded configuration (i.e., its native configuration).
For endovascular delivery of a device (e.g., the endograft devices 102 shown in
At a target site (e.g., above an aneurysm), the frame 104 self-expands to the expanded configuration shown in
Once deployed across the aneurysm, the frame 104 can also accommodate disparate anatomies and morphologies. In several patients, the aneurysmal sac extends at an angle with respect to the neck of the aneurysm. Because the frame 104 can have a braid angle θ that prevents kinking, the frame 104 can bend and flex without kinking to accommodate angulated aneurysmal sacs without restricting blood flow. Additionally, the unbound, woven wires 426 give the frame 104 a radial elasticity such that the frame 104 mimics the changes in the shape and morphology of the aorta without hindering the interface or seal between the endograft device and the vessel wall. For example, the frame 404 can constrict and expand to maintain the seal when pressure and other conditions alter the vasculature of the aorta. Moreover, the woven wires 426 inherently generate a spring force that biases the frame 104 toward a substantially straight trajectory within an aneurysmal sac and thereby limits migration of the endograft device.
In addition, the constant outward spring force and hoop strength of the braided frame 104 can be adjusted by changing the braid angle θ and/or the diameter of the wires 426. This allows the formation of large diameter frames 104 without a significant change in the low-profile cross-sectional dimensions. Additionally, this feature allows the frames 104 to contract to a much smaller introduction profiles (e.g., diameters) compared to standard Z-frames or M-frames because the standard Z-frames and M-frames tend to require more wire and therefore larger introduction profiles to maintain a constant outward spring force and hoop strength.
2.2 Covers
The ribs 530 of one cover can mate with opposing ribs 530 of an opposing cover and interface with vessel walls to enhance the seal and fixation between endograft devices in an endograft system (e.g., the endograft devices 102 of the endograft system 100 shown in
The ribs 530 change with the expansion and contraction of the cover 106. As shown in
Additionally, as shown in
The cover 106 can be made from a substantially impermeable, biocompatible, and flexible material. For example, the cover 106 can be made from synthetic polymers, polyurethanes, silicone materials, polyurethane/silicone combinations, rubber materials, woven and non-woven fabrics such as Dacron®, fluoropolymer compositions such as a polytetrafluoroethylene (PTFE) materials, expanded PTFE materials (ePTFE) such as TEFLON®, GORE-TEX®, SOFTFORM®, IMPRA®, and/or other suitable materials. Additionally, in some embodiments, the cover 106 can be made from a material that is sufficiently porous to permit ingrowth of endothelial cells. Such a porous material can provide more secure anchorages of endograft devices and potentially reduce flow resistance, sheer forces, and leakage of blood around the endograft devices.
In some embodiments in accordance with the technology, the cover 106 may also include drug-eluting coatings or implants. For example, the cover 106 can be coated and/or imbedded with a slow-releasing drug that can block cell proliferation, promote reendothelialization of the aneurysm, and/or otherwise medicate the aneurysmal region. Suitable drugs can include calcium, proteins, mast cell inhibitors, and/or other suitable medicines that encourage beneficial changes at the aneurysmal region.
In accordance with other embodiments of the technology, the cover 106 can be eliminated in favor of one or more layers of a coating material (shown and described in more detail with reference to
2.3 Integrated Frame and Cover
In the embodiment shown in
As shown in
Attaching the cover 106 to the exterior of the frame 104 as shown in
2.4 Alignment Aids
The alignment aid 734 can be made from radiopaque and/or fluoroscopic materials, such as tantalum, platinum, gold, and/or other materials that are visible under an imaging system (e.g., X-rays). For example, as shown in
2.5 Anchors
In an embodiment shown in
In one embodiment in accordance with the technology, the anchors 836 are separate elements that are attached to the frame 104. For example, in the embodiment shown in
The anchors 836 can be made from resilient metallic materials, polymeric materials (e.g., polyethylenes, polypropylenes, Nylons, PTFEs), and/or other suitable materials that can anchor the endograft devices 802 to arterial walls. For example, the interwoven anchors 836 shown in
3. Methods of Implementation and Assembled Endograft Systems
Described below are methods of deploying and assembling modular endograft systems across an aneurysm in accordance with embodiments of the technology. The associated Figures (i.e.,
3.1 Modular Endograft Systems
During deployment, the first catheter 42a and the first guidewire 44a are inserted percutaneously into a blood vessel (e.g., a femoral artery; not shown). With the aid of imaging systems, the first guidewire 44a is endoluminally navigated through the vasculature, up the first iliac artery 56a, and to a location superior to a target site T above the aneurysm 50. The first catheter 42a is then passed through the vasculature along the first guidewire 44a to the target site T. Using a generally similar method, the second guidewire 44b and the second catheter 42b are delivered through the second iliac artery 56b to the target site T. The first and second endograft devices 102a and 102b can be delivered simultaneously or in succession.
The endograft devices 102 can be urged out of the distal ends of the catheters 42 at the target site T by withdrawing the catheters 42 proximally while holding the endograft devices 102 in place using pushers or other suitable endovascular instruments. Alternatively, the endograft devices 102 can be pushed distally while holding the catheters 42 in place. Upon release, the endograft devices 102 self-expand to the expanded configuration shown in
Each endograft device 102 can be positioned at its desired location independently of the other endograft device 102 while the endograft devices 102 are in, or at least partially within, the catheters 42. For example, in the embodiment illustrated in
As further shown in
During deployment, the extension units 937 can be added to the system 100 after the first and second endograft devices 102 are positioned within the aortic neck 60. With the aid of the delivery system 40, the extension units 937 can advance along the guidewires 44 and be deployed from the catheters 42 at desired positions within, the first and second frames 104 just inferior of the renal arteries. Upon deployment, the extension units 937 can self-expand via an inherent spring force in the extension frame 904 to an expanded configuration to contact and at least substantially seal with the interior of the superior portions 108 of the endograft devices 102. As shown in
In some embodiments, alignment aids, such as the alignment aids 734 described with reference to
Compared to conventional devices that have a common height across the diameter of a vessel (e.g., the aorta), the staggered configuration shown in
The fenestrations 1038 can be openings through the cover 106 that expose the frame 104 and provide a channel through which blood can flow to and from transverse arteries. For example, the endograft devices 1002 can be positioned independently and staggered such that the fenestration 1038 of each endograft device 1002 is aligned with one of the left or right renal arteries. The fenestrations 1038 accordingly increase the available sealing area between the outer walls 112 and the arterial walls because the superior portions 108 can be positioned independently over the renal arteries such that one endograft device 1002 does not need to be limited to the elevation of the inferior renal artery. This provides optimal placement for each endograft device 1002 within the vasculature without requiring customized devices. In other embodiments in accordance with the technology, the endograft devices 1002 can include additional fenestrations 1038 to increase the available sealing area without restricting blood flow. For example, the inferior portions 110 can include fenestrations 1038 that allow the inferior portions 110 to extend over the entrance of the internal iliac arteries.
Referring to
Referring to
As shown in
The four-part, two-wire system 1300 can easily accommodate anatomical variations without requiring customized components. For example, the superior portions 108 can be staggered to maximize the mating and sealing area of each outer wall 112 with the aortic walls. Additionally, each limb 1362 can be selected from a relatively small number of different lengths to extend a desired length within the iliac arteries 56 that both adequately connects and substantially seals the limbs 1362 to the arterial walls and does not block transverse arterial flow. The limbs 1362 can also be adjusted independently relative to the inferior portions 110 to increase the available structure for fixing and sealing the limbs 1362 and the inferior portions 110 together, and to shorten or lengthen the limbs 1362 within the iliac arteries 56. Additionally, the braided structure of the frames 104 can decrease infolding of the covers 106 such that the lengths of the frame 104 can be selected from standardized cross-sectional dimensions. Thus, the four-part system 1300 can be highly customizable, but yet comprise standardized components.
3.2 Modular Endograft System with Aortic Cuff
The sleeve 1466 can be attached to the interior and/or exterior of the cuff frame 1468 using suitable fastening methods. For example, as shown in
The sleeve 1466 and the cuff frame 1468 can have a substantially cylindrical shape. In some embodiments, the aortic cuff 1464 can include two channels to support superior portions 108 of endograft devices 102 (
Referring to
In some embodiments in accordance with the technology, the aortic cuff 1464 can include alignment aids, such as the alignment aids 734 described above with reference to
In additional embodiments, the aortic cuff 1464 can include anchors, such as the anchors 836 described above with reference to
Referring to
As shown in
In the embodiments illustrated in
4. Methods of Manufacturing
4.1 Integrated Frame
Referring back to
The wire 426 can be removed from the mandrel after it is braided into the frame 104 and formed into a desired shape (e.g., the endograft devices 102 shown above). The frame 104 can then be heated to a shape-setting temperature specified for the wire material (e.g., Nitinol), and subsequently quenched. Optionally, the frame 104 can be annealed to increase the strength of the frame 104. The mandrel can be cylindrical or have the shape of the frame 104 such that the wire 426 remains on the mandrel during heat treatment. In further embodiments, the frame 104 can be manufactured using other suitable methods for shaping resilient biocompatible materials.
4.2 Covers and Coatings
Referring to
In other embodiments in accordance with the technology, coating layers can be used in place of or in conjunction with the cover 106.
Referring to
Once the first coating layer 1770 is applied over the frame 1704, the first coating layer 1770 and the frame 1704 can be heated on the mandrel 80 in an oven. For example, the first coating layer 1770 and the frame 1704 can be heated for less than thirty minutes in a 370° C. oven. After heating, the coated frame 1704 is removed from the mandrel 80 and extended and contracted from the low-profile configuration to the expanded configuration to ensure the first coating layer 1770 properly adhered to the frame 1704 during heat treatment.
As shown in
As shown in
From the foregoing, it will be appreciated that specific embodiments of the invention have been described herein for purposes of illustration, but that various modifications may be made without deviating from the spirit and scope of the technology. For example, the embodiments illustrated in
Claims
1. A modular endograft system, comprising:
- a first endograft device having a first superior portion, a first inferior portion, and a first lumen through the first superior and inferior portions, wherein the first superior portion has a first superior terminus, a first outer wall, and a first septal wall;
- a second endograft device having a second superior portion, a second inferior portion, and a second lumen through the second superior and inferior portions, wherein the second superior portion has a second superior terminus, a second outer wall, and a second septal wall;
- wherein the first and second septal walls of the first and second endograft devices press against one another and form a septum; and
- wherein the first superior terminus of the first endograft device is superior to the second superior terminus of the second endograft device such that the first and second endograft devices are longitudinally staggered and a free end portion of the first superior portion is positioned distally beyond the second superior terminus.
2. The modular endograft system of claim 1 wherein the first and second septal walls are convexly curved, and wherein:
- the first outer wall and the first septal wall define a first complex ellipsoid, wherein the first outer wall has a first radius and the first septal wall has a second radius greater than the first radius;
- the second outer wall and the second septal wall define a second complex ellipsoid, wherein the second outer wall has the first radius and the second septal wall has the second radius;
- the first and second complex ellipsoids have a substantially D-shaped cross section; and
- the first and second endograft devices are configured to self-expand via an inherent spring force such that the first and second septal walls exert opposing forces against each other.
3. The modular endograft system of claim 2 wherein the opposing forces between the first and second septal walls are substantially uniform along the septum.
4. The modular endograft system of claim 1 wherein the first and second septal walls are at least substantially straight along the septum and the free end portion of the first superior portion is at least substantially longitudinally aligned with the first septal wall at the septum.
5. The modular endograft system of claim 4 wherein the first endograft device has an integrated, self-expanding frame configured to have integrated, continuous support longitudinally along the frame such that each area of the frame influences the radial expansion or contraction of an adjacent area of the frame.
6. The modular endograft system of claim 1 wherein the first and second inferior portions have a substantially circular cross-section.
7. The modular endograft system of claim 1 wherein:
- the first endograft device has a first frame and a first cover attached to the first frame, the first cover having a plurality of first circumferential ribs;
- the second endograft device has a second frame and a second cover attached to the second frame, the second cover having a plurality of second circumferential ribs; and
- wherein the first and second circumferential ribs interface at the septum.
8. The modular endograft system of claim 1 wherein:
- the first septal wall is convexly curved in an opposite direction relative to the first outer wall, and the first septal wall and the first outer wall are joined at curved corners; and
- the second septal wall is convexly curved in an opposite direction relative to the second outer wall, and the second septal wall and the second outer wall are joined at curved corners.
9. The modular endograft system of claim 8 wherein:
- the first outer wall and the second outer wall each have a first radius of curvature;
- the first septal wall and the second septal wall each have a second radius of curvature greater than the first radius of curvature; and
- the curved corners have a radius of curvature less than the first radius of curvature, and wherein the curved corners form an angle from approximately 60° to approximately 100° at the septum in an expanded configuration.
10. The modular endograft system of claim 1 wherein the first endograft device has a first alignment aid and the second endograft device has a second alignment aid, wherein the first and second alignment aids are configured to indicate a rotational orientation and a longitudinal position of the first and second endograft devices relative to each other.
11. The modular endograft system of claim 1 wherein:
- the first endograft device has a first braided frame configured to have a spring force that self-expands radially outward from a constricted profile to an expanded profile and a first cover attached to the first braided frame, the first cover having a first inferior terminus and a first superior terminus, and the first braided frame having a first end extending distally beyond the first superior terminus of the first cover and second end extending proximally beyond the first inferior terminus of the first cover;
- the second endograft device has a second braided frame configured to have a spring force that self-expands radially outward from a constricted profile to an expanded profile and a second cover attached to the second braided frame, the second cover having a second inferior terminus and a second superior terminus, and the second braided frame having a first end extending distally beyond the second superior terminus of the second cover and a second end extending proximally beyond the second inferior terminus of the second cover; and
- wherein the first ends of the first and second frames include openings through which blood can flow laterally relative to the first and the second lumens.
12. The modular endograft system of claim 11, wherein the first and second braided frames are woven from wire such that each longitudinal segment of each frame supports adjacent longitudinal segments along the length of each frame.
13. The modular endograft system of claim 1 wherein the first and second endograft devices each include at least one anchor at the superior portion, wherein the anchor protrudes radially from the outer wall in the expanded configuration and constricts in a low-profile configuration.
14. The modular endograft system of claim 1 wherein:
- the first endograft device further includes a first transition portion between the first superior portion and the first inferior portion, the first transition portion tapering the first lumen from a first cross-sectional dimension at the superior portion to a second cross-sectional dimension less than the first cross-sectional dimension at the inferior portion, wherein the transition portion is configured to maintain substantially laminar blood flow through the first lumen in the expanded configuration; and
- the second endograft device further includes a second transition portion between the second superior portion and the second inferior portion, the second transition portion tapering the second lumen from the first cross-sectional dimension at the second superior portion to the second cross-sectional dimension at the second inferior portion, wherein the second transition portion is configured to maintain substantially laminar blood flow through the second lumen in the expanded configuration.
15. The modular endograft system of claim 1 wherein:
- the first endograft device has a first frame and a first cover attached to a portion of the first frame, the first frame comprising an open braided wire, and the first cover having a first opening at the first outer wall;
- the second endograft device has a second frame and a second cover attached to the second frame, the second frame comprising an open braided wire, and the second cover having a second opening at the second outer wall; and
- wherein the first and second openings allow blood to flow laterally relative to the first and second lumens.
16. The modular endograft system of claim 1 wherein:
- the first endograft device has a first frame and a first cover attached to a portion of the first frame, the first frame comprising an open braided wire, and the first cover having a first opening at the first inferior portion, and wherein the first opening allows blood to flow laterally through the first opening relative to the first lumen.
17. A modular endograft system, comprising:
- a first endograft device having a first frame, a first cover attached to the first frame, and a first lumen within the first cover, wherein the first frame and the first cover have a first superior portion and a first inferior portion, and the first superior portion has a convexly curved first outer wall and a first septal wall;
- a second endograft device having a second frame, a second cover attached to the second frame, and a second lumen within the second cover, wherein the second frame and the second cover have a second superior portion and a second inferior portion, the second superior portion having a convexly curved second outer wall and a second septal wall;
- wherein the first and second endograft devices are configured to be extended into a low-profile configuration with a first cross-sectional dimension and expand to an expanded configuration with a second cross-sectional dimension greater than the first cross-sectional dimension such that in the expanded configuration opposing portions of the first and second septal walls press against each other and form a septum between the first and second lumens; and
- wherein the first and second endograft devices are longitudinally staggered with respect to the each other in the expanded configuration such that the first frame includes a first free end portion projecting distally beyond the second superior portion of the second endograft device.
18. The modular endograft system of claim 17 wherein the first and second frames each include a superior terminus, an inferior terminus, and a continuous wire woven in a braid, the wire crossing itself at a braid angle, and the wire reversing direction at the superior terminus of the frame to form a first plurality of loops and reversing direction at the inferior terminus of the frame to form a second plurality of loops
19. The modular endograft system of claim 18 wherein the braid angle is from approximately 30° to approximately 45°.
20. The modular endograft system of claim 17 wherein:
- the first superior portion has a cross-sectional dimension of at least 20 mm in the expanded configuration and a cross-sectional dimension of at most 5 mm in the low-profile configuration; and
- the second superior portion has a cross-sectional dimension of at least 20 mm in the expanded configuration and a cross-sectional dimension of at most 5 mm in the low-profile configuration.
21. The modular endograft system of claim 17 wherein the first and second covers extend over the first and second frames, respectively, and wherein the first and second covers are configured to limit radial expansion and longitudinal contraction of the first and second frames in the expanded configuration.
22. The modular endograft system of claim 17 wherein:
- the first cover includes first ribs protruding radially from the first frame in the expanded configuration, the first ribs being extendable longitudinally in the low-profile configuration;
- the second cover includes second ribs protruding radially from the second frame in the expanded configuration, the second ribs being extendable longitudinally in the low-profile configuration; and
- wherein the first and second ribs interface at the septum in the expanded configuration.
23. The modular endograft system of claim 17 wherein:
- the first and second superior portions include alignment aids on opposing first and second septal walls, the alignment aids being configured to cross one another when the first and second septal walls form the septum.
24. The modular endograft system of claim 17 wherein:
- the first frame comprising an open braided wire and the first cover having a first opening at the first outer wall;
- the second frame comprising an open braided wire, and the second cover having a second opening at the second outer wall; and
- wherein the first and second openings allow blood to flow laterally relative to a longitudinal axis of the first lumen and second lumens.
25. The modular endograft system of claim 24 wherein the first cover of the first endograft device has a third opening at the first inferior portion, and wherein the third opening allows blood to flow laterally through the third opening from the first lumen.
26. A method of repairing an aneurysm in a primary blood vessel before a bifurcation into a first blood vessel and a second blood vessel, comprising:
- advancing a first endograft device through the first blood vessel to a target site in the primary blood vessel before the aneurysm;
- advancing a second endograft device through the second blood vessel to the target site independently of advancing the first endograft device through the first blood vessel;
- deploying the first and second endograft devices at the target site by separately expanding the first and second endograft devices to an expanded configuration such that opposing portions of first and second septal walls of the first and second endograft devices, respectively, press against each other to form a septum between the first and second endograft devices; and
- wherein a first superior portion of the first endograft device is longitudinally staggered relative to a second superior portion of the second endograft device such that a free end portion of the first superior portion projects distally beyond a terminus of the second endograft device.
27. The method of claim 26, further comprising:
- loading the first endograft device in a first catheter, wherein the first endograft device is extended in a low-profile configuration;
- loading the second endograft device in a second catheter, wherein the second endograft device is extended in a low-profile configuration;
- percutaneously introducing the first endograft device into the first blood vessel; and
- percutaneously introducing the second endograft device into the second blood vessel.
28. The method of claim 27 wherein the first and second endograft devices have a cross-sectional dimension no less than 20 mm in the expanded configuration, and wherein the first and second catheters are no larger than 12 F.
29. The method of claim 26 wherein the first endograft device includes a first alignment aid at the first septal wall and the second endograft device includes a second alignment aid at the second septal wall, the first and second alignment aids comprising a radiopaque material, and wherein deploying the first and second endograft devices further includes:
- radiographically positioning the first and second alignment aids such that the first and second alignment aids oppose one another;
- viewing the first and second alignment aids in the orthogonal plane; and
- crossing the first and second alignment aids such that the first and second septal walls form the septum.
30. The method of claim 29 wherein the first and second alignment aids diagonally cross the first and second septal walls, and wherein the first and second alignment aids form an “X” indicator at the septum.
31. The method of claim 26 wherein the first and second endograft devices each include a frame and a cover, at least a portion of the cover being attached over the frame, and at least a portion of the cover having a plurality of circumferential ribs projecting radially from the frame, and wherein deploying the first and second endograft devices further comprises:
- interfacing the circumferential ribs at the first septal wall with the circumferential ribs at the second septal wall at the septum; and
- interfacing the circumferential ribs at the first and second outer walls with a vessel wall of the primary blood vessel.
32. The method of claim 26 wherein the first and second endograft devices each include a cover attached over at least a portion of a frame, and deploying the first and second endograft devices further comprises restricting radial expansion of the frames with the covers.
33. The method of claim 26 wherein the primary blood vessel is an aorta and the first blood vessel is a first common iliac artery and the second blood vessel is a second common iliac artery, and wherein deploying the first and second endograft devices further includes:
- at least substantially sealing a proximal end of a first inferior portion of the first endograft device with an arterial wall of the first common iliac artery; and
- at least substantially sealing a proximal end of a second inferior portion of the second endograft device with an arterial wall of the second common iliac artery.
34. The method of claim 26 wherein the first septal wall is convexly curved in a direction opposite a first outer wall of the first endograft device and a second septal wall of the second endograft device is convexly curved in a direction opposite the second outer wall, and wherein deploying the first and second endograft devices comprises urging opposing portions of the convexly curved first and second septal walls together.
35. The method of claim 34 wherein urging convexly the curved first and second septal walls together results in a substantially uniform distribution of pressure between the opposing portions of the first and second septal walls.
36. The method of claim 26 wherein the primary blood vessel includes a third blood vessel and a fourth blood vessel branching from the primary blood vessel before the aneurysm, the third and fourth blood vessels being longitudinally offset from one another relative to the primary blood vessel, and wherein:
- the first endograft device has a first braided frame and a first cover coupled to the first braided frame, the first cover having a first inferior terminus and a first superior terminus, and the first braided frame having a first end extending distally beyond the first superior terminus of the first cover and second end extending proximally beyond the first inferior terminus of the first cover, wherein the first and second end portions include openings through which blood can flow laterally relative to a longitudinal axis of the first lumen;
- the second endograft device has a second braided frame and a second cover attached to the second braided frame, the second cover having a second inferior terminus and a second superior terminus, and the second braided frame having a first end extending distally beyond the second superior terminus of the second cover and a second end extending proximally beyond the second inferior terminus of the second cover, wherein the first and second end portions include openings through which blood can flow laterally relative to a longitudinal axis of the second lumen; and
- staggering the first and second endograft devices comprises positioning the first end portion of the first frame at the entrance of the third blood vessel and positioning the first end portion of the second frame at the entrance of the fourth blood vessel such that the third and fourth blood vessels are in fluid communication with blood flow through the first and the second lumens.
37. The method of claim 26 wherein the primary blood vessel includes a third blood vessel and a fourth blood vessel branching from the primary blood vessel before the aneurysm, the third and fourth blood vessels being longitudinally, offset from one another relative to the primary blood vessel, and wherein:
- the first endograft device includes a first frame and a first cover attached to a portion of the first frame, the first frame comprising an open braided wire, and the first cover having a first opening at the first outer wall;
- the second endograft device includes a second frame and a second cover attached to the second frame, the second frame comprising an open braided wire, and the second cover having a second opening at the second outer wall, wherein the first and second openings allow blood to flow laterally relative to a longitudinal axis of the first and second lumens; and
- staggering the first and second endograft devices comprises positioning the first opening of the first frame at the entrance of the third blood vessel and positioning the second opening of the second frame at the entrance of the fourth blood vessel such that the third and fourth blood vessels are in fluid communication with blood flow through the first and the second lumens.
38. The method of claim 26 wherein the first blood vessel includes a third blood vessel branching from the first blood vessel after the aneurysm, and wherein:
- the first endograft device includes a first frame and a first cover attached to a portion of the first frame, the first frame comprising an open braided wire, and the first cover having a first opening at the first inferior portion; and
- the method further comprises positioning the first opening of the first frame at the entrance of the third blood vessel such that blood from the first lumen flows laterally through the first opening to the third blood vessel.
39. The method of claim 26 wherein the first and second endograft devices include first and second frames, respectively, and the first and second frames are configured to provide continuous support such that the free end portion at least substantially aligned with the first septal wall at the septum.
Type: Application
Filed: Dec 1, 2010
Publication Date: Jun 2, 2011
Applicant: Altura Medical, Inc. (San Clemente, CA)
Inventors: Andrew H. Cragg (Edina, MN), Stephen Sosnowski (Vista, CA), Isa Rizk (San Diego, CA), John Fulkerson (Rancho Santa Margarita, CA), John Logan (Plymouth, MN)
Application Number: 12/958,381